Effect of eculizumab in a patient with cold agglutinin disease. Levels of hemolysis (as measured by LDH, ○) and anemia (hemoglobin, ▲) were documented in the year before and after initiation of eculizumab treatment. Transfusion episodes (↑) are also shown.